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The 8–10 million European Roma/Gypsies are a founder population of common origins that has subsequently
split into multiple socially divergent and geographically dispersed Gypsy groups. Unlike other founder populations,
whose genealogy has been extensively documented, the demographic history of the Gypsies is not fully understood
and, given the lack of written records, has to be inferred from current genetic data. In this study, we have used
ﬁve disease loci harboring private Gypsy mutations to examine some missing historical parameters and current
structure. We analyzed the frequency distribution of the ﬁve mutations in 832–1,363 unrelated controls, representing
14 Gypsy populations, and the diversiﬁcation of chromosomal haplotypes in 501 members of affected families.
Sharing of mutations and high carrier rates supported a strong founder effect, and the identity of the congenital
myasthenia 1267delG mutation in Gypsy and Indian/Pakistani chromosomes provided the best evidence yet of the
Indian origins of the Gypsies. However, dramatic differences in mutation frequencies and haplotype divergence and
very limited haplotype sharing pointed to strong internal differentiation and characterized the Gypsies as a founder
population comprising multiple subisolates. Using disease haplotype coalescence times at the different loci, we
estimated that the entire Gypsy population was founded ∼32–40 generations ago, with secondary and tertiary
founder events occurring ∼16–25 generations ago. The existence of multiple subisolates, with endogamymaintained
to the present day, suggests a general approach to complex disorders in which initial gene mapping could be
performed in large families from a single Gypsy group, whereas ﬁne mapping would rely on the informed sampling
of the divergent subisolates and searching for the shared genomic region that displays the strongest linkage dis-
equilibrium with the disease.
Introduction
Founder populations have been an invaluable resource
for understanding the molecular basis of Mendelian dis-
orders (Motulsky 1995; Risch et al. 1995; de la Chapelle
and Wright 1998; Shefﬁeld et al. 1998; Peltonen et al.
1999; Ostrer 2001; Arcos-Burgos and Muenke 2002),
and their (still-disputed) potential to contribute to re-
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search into genetically complex disorders is closely re-
lated to demographic history and population structure.
Linkage disequilibrium (LD) approaches to gene map-
ping are sensitive to time since founding, number of
founders, extent of genetic isolation, substructure, and
frequency and age of the genetic variant (de la Chapelle
and Wright, 1998; Kruglyak 1999; Wright et al. 1999;
Peltonen et al. 2000; Shifman and Darvasi 2001; Heu-
tink and Oostra 2002).
Recent studies have identiﬁed novel single-gene dis-
orders and private mutations among the Roma (Gypsies),
drawing attention to this previously ignored founderpop-
ulation (Kalaydjieva et al. 1996, 2000; Piccolo et al.
1996; Abicht et al. 1999; Rogers et al. 2000; Varon et
al. 2003). Unlike other founder populations, whose his-
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tory and genealogy have been extensively documented
(Gulcher and Stefansson 1998; Agarwala et al. 1999;
Scriver 2001; Norio 2003), the Gypsy population is char-
acterized by a lack of reliable records, a nomadic tradi-
tion, and dispersal as an underprivileged ethnic minority
in numerous countries, which has resulted in the need to
infer their demographic history and genealogy from cur-
rent genetic data.
Cultural anthropology, linguistics, and limited his-
torical records from the surrounding majority popula-
tions describe the Gypsies as a population of Indian
origins, with their exodus from India dated to approx-
imately the 5th–10th century A.D., their arrival in By-
zantium dated to the 11th or 12th century, and their
dispersal throughout Europe documented by the end of
the 15th century (Fraser 1992; Marushiakova and Po-
pov 1997). Upon arrival in Europe, a large fraction of
the initial migrant population (referred to as “Balkan
Gypsies”) settled permanently in the Balkans south of
the Danube. Others, known as “Vlax Roma,” moved
north into Wallachia (present-day Romania), while the
remainder continued the journey to all parts of the con-
tinent (Fraser 1992). Superimposed on these early mi-
grations are several recent migration waves—out of Ro-
mania at the end of the 19th century and out of the
Balkans in the second half of the 20th century—as well
as multiple movements of small nomadic groups (Fraser
1992). The social organization of the Gypsies, similar
to the endogamous professional jatis of India, includes
numerous Gypsy groups with ethnonyms reﬂecting tra-
ditional trades. Group identity is based on traditions,
customs, language, trades, history of migrations, and
religion (Petulengro 1915–1916; Fraser 1992; Liegeois
1994; Marushiakova and Popov 1997).
Geographically dispersed and socially and linguisti-
cally divergent Gypsy groups have been shown to share
unique Mendelian disorders and founder mutations (Ka-
laydjieva et al. 1996, 2000; Piccolo et al. 1996; Abicht
et al. 1999; Rogers et al. 2000; Varon et al. 2003), as
well as ancestral Y chromosome and mtDNA lineages
(Gresham et al. 2001; Kalaydjieva et al. 2001a). Analysis
of the distribution and diversity of these lineages has
resulted in characterization of the current genetic proﬁle
of the Gypsies as the product of profound population
bottlenecks, random genetic drift, and differential ad-
mixture, correlating best with the historical migrations
within Europe (Gresham et al. 2001; Kalaydjieva and
Morar 2003).
In this study, we have obtained new information on
ﬁve loci harboring private disease-causing mutations
that are thus likely to reﬂect the history of the Gypsy
population rather than recent admixture. The combined
data were used to infer some of the missing parameters
relevant to the comprehensive characterization of the
population history of the Gypsies. The frequency and
distribution of the selected mutations and the diversi-
ﬁcation of the surrounding chromosomal haplotypes
were used to examine the times of founding, the extent
of genetic differentiation, and the implications of pop-
ulation history for the mapping of disease genes.
Subjects and Methods
Subjects
The study included a total of 1,870 subjects. The
Gypsy sample consisted of 1,363 unrelated healthy con-
trol individuals and 501 members of affected families
(241 affected subjects and 260 unaffected relatives). The
remaining six individuals were patients with congenital
myasthenia syndrome (CMS [MIM 254210]) who were
of Indian or Pakistani origin and were homozygous for
the 1267delG mutation.
The 1,363 Gypsy control individuals were tested for
the presence of the ﬁve disease mutations (table 1), to
estimate carrier frequencies in different Gypsy groups.
The number of subjects tested for the individualmutations
ranged from 832, for congenital cataracts facial dys-
morphism neuropathy (CCFDN [MIM 604168]), to
1,363, for limb-girdle muscular dystrophy 2C (LGMD2C
[MIM 253700]). The samples from Bulgaria were col-
lected as part of a pilot community-based carrier-testing
program, with pre- and postdiagnostic information and
counseling provided to all participating individuals.
The 501 subjects from affected Gypsy families were
participants in earlier studies aimed at the positional
cloning of disease genes and the identiﬁcation of path-
ogenic mutations. These samples, together with those
from the six Indian/Pakistani subjects, were used for the
analysis of chromosomal haplotype surrounding the he-
reditary motor and sensory neuropathy–Lom (HMSNL
[MIM 601455]), CCFDN, CMS, and LGMD2C muta-
tions (table 2). Disease haplotypes in the region of the
GALK1 gene have been reported elsewhere (Kalaydjieva
et al. 1999; Hunter et al. 2002).
Background LD in the HMSNL and CCFDN gene
regions was examined using the nontransmitted chro-
mosomes of the affected families from the Rudari, Kald-
erash, and Lom Gypsy groups. Additional genotyping
data for the same regions were obtained by analyzing
unaffected families from the Turgovzi group.
Informed consent has been obtained from all partic-
ipants. The study complies with the ethical guidelines of
the institutions involved.
Ethnic Composition of the Sample
We have collected information aimed toward classi-
fying the different Gypsy populations in accordancewith
historical and cultural anthropological criteria. Subjects
from Bulgaria were assigned to Gypsy groups (tables 1
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Table 1
Sample Sizes and Estimated Carrier Rates (%) in Gypsy Groups Screened for Five Founder Mutations
MIGRATIONAL CATEGORY
AND GYPSY GROUP IDENTITY
NO. OF INDIVIDUALS TESTED (N) AND CARRIER RATE (CR) FOR MUTATION
1267delG
(CMS)
R148X
(HMSNL)
P28T
(GKD)a
C283Y
(LGMD2C)
IVS6389CrT
(CCFDN)b
N
CR
(%) N
CR
(%) N
CR
(%) N
CR
(%) N
CR
(%)
Balkan:
Darakchii 54 5.56 54 .00 54 1.85 54 5.56 54 .00
Kalaidjii North 96 5.21 91 4.40 95 1.05 95 .00 83 .00
Blacksmiths 63 6.35 63 .00 60 .00 63 .00 63 .00
Musicians 62 .00 62 3.23 62 .00 61 1.64 57 1.75
Feredjelli 43 .00 43 .00 39 .00 101 .00 42 2.38
Turgovzi 65 .00 56 1.79 56 .00 224 6.25 57 .00
Xoroxane 36 5.56 36 2.78 35 2.86 38 .00 31 .00
Subtotal 419 3.34 405 1.98 401 .75 636 2.83 387 .52
Vlax:
Rudari 138 1.45 139 11.51 139 2.88 113 .00 115 6.96
Kalderash 41 .00 41 9.76 84 2.38 41 .00 41 2.44
Lom 124 6.45 124 16.13 124 6.45 123 .00 124 .00
Kalaidjii South 63 7.94 63 .00 63 .00 63 .00 61 .00
Subtotal 366 4.10 367 10.90 410 3.41 340 .00 341 2.64
Western European:
Hungarian 283 4.95 293 .34 310 .00 293 1.37 NT NT
Lithuanian 20 .00 20 5.00 19 .00 20 .00 20 .00
Spanish 87 1.15 80 2.50 161 1.86 74 1.35 84 1.19
Subtotal 390 3.85 393 1.02 490 .61 387 1.29 104 .96
Total 1,175 3.74 1,165 4.46 1,301 1.54 1,363 1.69 832 1.44
a GKD p galactokinase deﬁciency.
b NT p not tested.
and 2 and ﬁg. 1) on the basis of self-reported identi-
ty and a linguistic interview. Through use of existing
cultural anthropology data (Marushiakova and Popov
1997), the groups were classiﬁed into larger migrational/
linguistic categories: Balkan and Vlax. In two cases, self-
reported identity did not specify an individual Gypsy
group but referred to larger cultural-anthropological di-
visions within the Balkan category: the Xoroxane (Mus-
lim) and Dassikane (Christian). The Rudari from other
Balkan countries were classiﬁed on the basis of linguistic
data. The remaining subjects were broadly assigned to
migrational categories: Vlax and Balkan.
Individuals from Hungary, Slovenia, the Czech Re-
public, Lithuania, Germany, France, Italy, Spain, and
Portugal, for whom information on Gypsy group iden-
tity was unavailable, partial, or contradictory, were clas-
siﬁed together as “western European.” The available in-
formation on Indian/Pakistani subjects indicated diverse
areas of origin (Uttar Pradesh, Andhra Pradesh, South-
ern India, and north of Islamabad in Pakistan), caste
(Rajpoot, Kamma), and language groups (Urdu, Telugu).
Diseases and Founder Mutations
HMSNL, caused by a premature termination codon
(R148X) in NDRG1 on 8q24, is a severe early-onset
peripheral neuropathy, diagnosed in individuals from di-
verse Gypsy populations across Europe (Kalaydjieva et
al. 1996, 1998, 2000).
CCFDN, caused by the splicing IVS6389CrT mu-
tation in CTDP1 on 18qter, is a developmental disorder
conﬁned to a single Gypsy group of the Vlaxmigrational
category (Angelicheva et al. 1999; Tournev et al. 1999;
Varon et al. 2003).
CMS occurs in diverse Gypsy groups (Abicht et al.
1999). The founder mutation, 1267delG in CHRNE on
17p13, was identiﬁed originally in patients from India/
Pakistan (Croxen et al. 1999).
LGMD2C, caused by C283Y in SGCG on 13q12, is
a Duchenne-like disorder in Gypsy patients fromwestern
Europe and in speciﬁc Balkan Gypsy groups (Piccolo et
al. 1996; Merlini et al. 2000).
Galactokinase deﬁciency (MIM 230200), caused by
P28T in GALK1 on 17q24, is an inborn error of ga-
lactose metabolism with development of infantile cata-
racts and is found across Europe; it is most common
among the Vlax Gypsies (Kalaydjieva et al. 1999; Hun-
ter et al. 2002).
Detailed accounts of the clinical phenotypes and of
the genetic characterization of the disease loci have been
provided in the references cited above.
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Table 2
Origins and Sample Sizes of Disease and Control Chromosomes Included in the Haplotype Analysis
of the Four Gene Regions
MIGRATIONAL CATEGORY,
CURRENT RESIDENCE, AND
GYPSY GROUP IDENTITY
NO. OF DISEASE CHROMOSOMES
NO. OF NORMAL
CHROMOSOMES
CHRNE
(CMS)
NDRG1
(HMSNL)
SGCG
(LGMD2C)
CTDP1
(CCFDN)
Balkan:
Bulgaria:
Darakchii 3 0 0 0 0
Kalaidjii North 4 0 0 0 0
Blacksmiths 4 4 0 0 0
Turgovzi 0 0 48 0 0
Xoroxane 15 15 0 0 0
Dassikane 16 6 0 0 0
Other Balkan countries:
Unspeciﬁed 22 0 0 0 0
Subtotal 64 25a 48 0 56
Vlax:
Bulgaria:
Rudari 0 35 0 74 0
Kalderash 0 32 0 4 0
Lom 12 18 0 0 0
Kalaidjii South 9 0 0 0 0
Other Balkan countries:
Rudari 0 0 0 42 0
Unspeciﬁed 2 16 0 0 0
Subtotal 23a 101a 0 120 163
Western European 47a 14 30 9 41
Other:
India/Pakistan 12 0 0 0 0
Total 146 140 78 129b 260
a Includes a nontransmitted chromosome from an affected family member of the proband.
b Three recent recombinations in families with CCFDN were counted separately, giving an odd
number of chromosomes.
Genotyping Analyses
Blood samples obtained during ﬁeldwork in Bulgaria
were collected in AS1 buffer (QIAGEN) or on FTA cards
(Life Technologies). DNA was extracted following the
manufacturers’ instructions. DNA samples from other
countries were extracted from white blood cells through
use of standard protocols.
PCR-based RFLP assays were used to detect the ﬁve
mutations (table A [online only]). The digested products
were resolved by agarose gel electrophoresis and visu-
alized with ethidium bromide staining.
Haplotype analysis was performed using 8 markers
over 9.96 cM for the CMS region, 11 markers over 7.61
cM for HMSNL, 5 markers over 3.86 cM for LGMD2C,
and 16 markers over 5.34 cM for CCFDN (ﬁg. 2). Most
markers were microsatellite repeats, except LOC125267,
LOC125261, DIM1, and PAR6 in the CCFDN region,
which were insertion/deletions. Details on most markers
are available in the public databases. Polymorphisms iden-
tiﬁed during the positional cloning of the HMSNL and
CCFDN genes have been reported elsewhere (Chandler
et al. 2000; Varon et al. 2003). For the genotyping, we
used multiplex PCR with 5′ ﬂuorescent labeling of one
primer/pair, electrophoretic separation on an ABI 377
DNA Analyzer, and fragment analysis with Genotyper
version 2.5.
Data Processing
Allele frequencies for the ﬁve founder mutations were
estimated using the carrier rates data. Pairwise differ-
ences in carrier frequencies were assessed for statistical
signiﬁcance through use of Fisher’s exact test. The ge-
netic afﬁnities of Gypsy groups were examined using the
gene frequency data and Nei’s standard genetic distance
(Nei 1987). The software package DISPAN (Ota 1993)
was used to generate a population tree on the basis of
the neighbor-joining method (Saitou and Nei 1987).
Haplotypes were constructed manually from the family
genotyping data. Marker order and distances (ﬁg. 2) fol-
lowed the deCODE map (Kong et al. 2002; National
Center for Biotechnology InformationGenomeViewWeb
site). For markers not included in the public geneticmaps,
genetic distances were extrapolated from the physical
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Figure 1 Assignment of participating subjects to migrational/linguistic categories and individual Gypsy groups within the categories. The
Xoroxane and Dassikane (indicated with an asterisk [*]) do not specify individual Gypsy groups but represent broader cultural anthropological
divisions within the Balkan category, in which group identity has been lost. The western European migrational category comprises subjects
from Hungary, Slovenia, the Czech Republic, Lithuania, Germany, France, Italy, Spain, and Portugal.
maps. The core conserved haplotypes included markers
close to the disease mutation, and variation in the pe-
ripheral markers was used to infer haplotype genealogy.
Haplotypes sharing the same historical recombination
closest to the disease locus were assigned to the same
haplotype group, designated with a letter. Within each
haplotype group, further diversiﬁcation at more periph-
eral loci generated derivative haplotypes, which were
given unique numbers. On the basis of these relationships,
a haplotype network was constructed manually, in which
the most likely founding haplotype was inferred from al-
lele states at loci close to the disease mutation, the fre-
quency and population distribution of the haplotype, and
the diversity of its derivative haplotypes.
Arlequin version 2 (Schneider et al. 2000) was used
to estimate haplotype diversity and FST values for each
locus and each data set, as well as to examine population
differentiation through use of exact tests based on hap-
lotype frequencies. For direct comparisons of diversity,
we analyzed haplotypes over comparable regions of ∼3
cM around the disease loci.
Haplotype coalescence times in generations (G) were
estimated using a Bayesian approach and the DMLE
software package (Rannala and Slatkin 1998; Reeve and
Rannala 2002), which takes into account the marker
information from the entire haplotype (independent of
the inferred haplotype genealogy and of the network
discussed in the previous section). We have used a gen-
eration time of 25 years and a population growth rate
(g) of 1.32, as estimated previously (Hunter et al. 2002).
Mutation carrier rates determined in the present study
were used in conjunction with population size to esti-
mate the fraction of the population sampled for each
coalescence time calculation. The haplotypes on non-
transmitted chromosomes, characterized in the family
analyses, were used as control data. Each run was per-
formed at least twice, with a minimum of 1,000,000
burn-ins preceding a minimum of 1,000,000 “real”
iterations.
LD around the disease mutations was assessed using
, where paffected isp p (p  p )/(1 p )excess affected normal normal
the frequency of the disease-associated allele and pnormal
is the frequency of that allele in the general population
(Hastbacka et al. 1992, 1994). To evaluate background
LD, we calculated D′ through use of GOLD software
(Abecasis and Cookson 2000) and calculated empirical
P values through use of the Markov-chain method of
Guo and Thompson (1992) and Arlequin version 2
(Schneider et al. 2000). The step-down Holm Sidak pro-
cedure, described by Lautenberger et al. (2000), was
used to correct for multiple marker-pair comparisons.
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Figure 2 Genetic maps used in the haplotype analysis of four of the founder mutations. Markers are shown as equidistant from one
another. The position of the mutation is indicated with a black square. Markers designated with an “S” number are known microsatellites
found in public databases. Microsatellites identiﬁed during positional cloning studies include SLAP (NDRG1 region), 23090ta1, 1908ca1,
21594at1, 68530gt1, 68530ca1, and 68530gt2 (CTDP1 region). LOC125267, LOC125261, DIM1, and PAR6 in this region represent insertion/
deletion polymorphisms. Markers in boldface type were included in the comparative analysis of regions spanning ∼3 cM around each disease
mutation. A, CHRNE on 17p13.2. B, NDRG1 on 8q24.22. C, SGCG on 13q12.12. D, CTDP1on 18qter.
Results
Mutation Frequencies
We identiﬁed a total of 151 individuals heterozygous
for one of the ﬁve disease-causing mutations. The cu-
mulative carrier rate (averaged across the population)
was 12.9%. Carrier rates for individual mutations
ranged from ∼1.4% to 4.5% (table 1).
The distribution of mutations differed between mi-
grational categories (table 1). The HMSNL, GALK, and
CCFDN mutations were present in all categories but
were more common among the Vlax Gypsies, whereas
LGMD2C was fully conﬁned to the Balkan and western
European Gypsies. In contrast, the CMS mutation oc-
curred at approximately equal frequencies in all migra-
tional categories. Pairwise comparisons between the
Vlax and Balkan migrational categories in Bulgaria re-
vealed signiﬁcant differences in the frequencies of the
HMSNL ( ), CCFDN ( ), galacto-7P ! 3# 10 P ! .029
kinase deﬁciency ( ), and LGMD2C ( )P ! .012 P ! .0006
mutations but no difference for the CMS mutation.
When all loci were taken into account, the difference
between the Balkan and Vlax migrational categories was
highly signiﬁcant ( ).P ! .00014
Mutation frequencies also differed markedly between
individual Gypsy groups within each migrational cate-
gory, as exempliﬁed by CCFDN and LGMD2C, with
carrier rates of ∼5%–7% in speciﬁc groups (the Rudari
for CCFDN and Darakchii and Turgovzi for LGMD2C)
and rates that were much lower or zero in other groups
of the same migrational category.
In the neighbor-joining tree based on all disease gene
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Figure 3 Neighbor-joining tree of Gypsy groups, based on the
gene frequency data obtained from the population screening of the
ﬁve disease mutations and Nei’s standard genetic distance (Nei 1987).
The tree was generated using the DISPAN package (Ota 1993), on the
basis of the neighbor-joining method (Saitou and Nei 1987). The num-
bers indicate the robustness of the branches in the tree, assessed with
a bootstrap approach.
frequency data (ﬁg. 3), the Rudari, Lom, and Kalderash
groups from the Vlax migrational category were clus-
tered separately from the Balkan groups. No pattern
correlating with the Balkan and western European cat-
egories was apparent.
Disease Haplotypes
Closely related haplotypes at the CMS, HMSNL,
CCFDN, and LGMD2C loci were observed in all Gypsy
chromosomes, supporting the common origins of the
mutations (tables B–E [online only]). In the CMS region,
both Indian/Pakistani and Gypsy chromosomes dis-
played allele 4 at marker D17S1175, 9.76 kb from the
disease mutation, and 121/134 Gypsy and 10/12 Indian/
Pakistani chromosomes also shared an identical 1.49-
cM three-marker haplotype (table B [online only]). We
conclude that the CMS 1267delG mutation in the two
populations is derived from a common ancestor. The
diverse geographic, linguistic, caste, and religious afﬁl-
iations of the Indian/Pakistani patients suggest both an
old age and a wide geographic dispersal of the mutation
in the Indian subcontinent.
Haplotype diversity and coalescence times.—In the
CMS region (table B [online only]), we identiﬁed 91
haplotypes among 134 Gypsy chromosomes and 103
haplotypes in the entire sample of 146 chromosomes
(including the Indian/Pakistani), with a mean SD hap-
lotype diversity index (HDI) of . Hap-0.987 0.003
lotypes were assigned to 13 groups, of which groups A,
B, and C accounted for ∼80% of chromosomes.
The 140 HMSNL chromosomes (table C [online
only]) presented with a total of 84 haplotypes (HDI
), which fell into 20 different haplotype0.984 0.004
groups, with groups A and B accounting for 75% of
disease chromosomes. Analysis of the CCFDN region
revealed 54 haplotypes among 129 chromosomes (HDI
), with haplotype groups A and B occur-0.947 0.012
ring in 190% of chromosomes (table D [online only]).
The LGMD2C region showed limited diversity (HDI
), with only 16 haplotypes observed0.741 0.039
among 78 disease chromosomes. Haplotypes fell into a
single group, with A1, A2, and A9 accounting for 175%
of chromosomes (table E [online only]).
To obtain a direct comparison among the four loci,
we reexamined haplotype diversity in similar ∼3-cM in-
tervals. Diversity at the HMSNL, CMS, and CCFDN
loci decreased by ∼10% (HDI ∼0.850 for all) and re-
mained considerably higher than that for LGMD2C
(HDI ), indicating that differences in hap-0.741 0.039
lotype length introduced minimal bias.
We used the haplotype data at the different loci to
estimate coalescence times in the entire Gypsy popula-
tion, in migrational categories, and in individual Gypsy
groups (table 3). Haplotypes surrounding thewidely rep-
resented CMS 1267delG and HMSNL R148X muta-
tions were used to examine coalescence times for the
entire population. The dates obtained with the DMLE
software were 800 (95% CI 650–1,025) years for
1267delG and 850 (700–1,075) years for R148X. An
alternative method (Stephens et al. 1998) produced sim-
ilar estimates of ∼900 years for both mutations. The
LGMD2C mutation C283Y, limited to the Balkan and
western European Gypsies, showed an overall haplotype
coalescence time of ∼600 (525–775) years, and a time
of 725 years was obtained with the Stephens et al. (1998)
method. DMLE estimates of haplotype coalescence
times for the CMS, HMSNL, and LGMD2C mutations
in the different migrational categories ranged between
475 (375–700) years for CMS in the Vlax Gypsies and
600 (475–825) years for HMSNL in the Vlax and west-
ern European Gypsies. The dating in individual Gypsy
groups produced values between 425 (300–650) years
for HMSNL in the Lom and LGMD2C in the Turgovzi
and 600 (500–775) years for HMSNL in the Rudari.
Haplotype genealogy and LD mapping.—Weobserved
different patterns of the haplotype networks, reﬂecting
the age and history of the mutations. The CMS 1267delG
mutation, whose presence in subjects from many parts of
the Indian subcontinent pointed to its old age and wide
dispersal, presented with a complex genealogy (ﬁg. 4A).
The major haplotype groups were represented and nearly
evenly distributed in all Gypsy migrational categories and
in Indian/Pakistani chromosomes, and unique haplotypes
were shared between migrational categories (11% were
shared by Balkan and Vlax Gypsies, and 6% were shared
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Table 3
DMLE+ Estimates of Mutation Ages Obtained Using a Growth Rate of 1.32
POPULATION
MEAN (95% CI) AGE OF MUTATIONa
(years)
CHRNE
(CMS)
NDRG1
(HMSNL)
SGCG
(LGMD2C)
CTDP1
(CCFDN)
Entire sample 800 (650–1,025) 850 (700–1,075) 600 (525–775)b …
Migrational category:
Balkan 550 (450–775) 550 (450–750) … …
Vlax 475 (375–700) 600 (525–825) … …
Western European 550 (450–775) 600 (475–825) 525 (450–750) …
Individual group:
Rudari … 600 (500–775) … 500 (400–650)
Kalderash … 500 (375–675) … …
Lom … 425 (300–650) … …
Turgovzi … … 425 (375–650) …
a A generation time of 25 years was used in all estimates.
b The “entire” Gypsy sample in this case does not include the Vlax Gypsies, in whom LGMD2C
does not occur.
between Balkan and western European Gypsies). Hap-
lotype distribution showed no difference between the Bal-
kan and Vlax migrational categories but was signiﬁcantly
different ( for FST and Fisher’s exact test) betweenP ! .001
these two and the western European category.
In contrast to CMS, the HMSNL haplotype network
showed clustering by migrational categories (ﬁg. 4B) and
very limited sharing of haplotype groups and unique
haplotypes. No haplotype occurred in all migrational
categories, and !3% (2 rare haplotypes out of 76) were
shared by the Balkan and Vlax categories (FST analysis
; Fisher’s exact test ). We also observedP ! .05 P ! .001
a striking lack of haplotype sharing between Gypsy
groups in the Vlax category; no haplotype was common
to all three groups, and only one occurred in two groups
(ﬁg. 4C). The differences were highly signiﬁcant, with
for FST comparisons involving the Lom,P ! .001 P !
for the Rudari and Kalderash, and for all.05 P ! .001
comparisons using Fisher’s exact test.
The younger CCFDN and LGMD2C mutations, con-
ﬁned to individual Gypsy groups, presented with simple
haplotype genealogy (ﬁg. 4D and 4E). In the CCFDN
region, the two major haplotype groups occurred in Ru-
dari communities from different European countries,
with sharing of ∼10% of unique haplotypes yet signif-
icant geographic differences in haplotype distribution
( for FST analysis and for Fisher’s exactP ! .05 P ! .001
test). LGMD2C haplotypes showed a relatively high de-
gree of sharing, with 25% of unique haplotypes occur-
ring in both the Balkan and western European categories
and an obvious secondary founder effect in western Eu-
ropean Gypsies. Again, haplotype frequency distribu-
tions differed markedly ( for FST analysis andP ! .001
for Fisher’s exact test).
Haplotype divergence and limited sharing were re-
ﬂected in the LD analysis of the CMS, HMSNL, and
CCFDN gene regions (ﬁg. 5A–5D). The pexcess analysis
(Hastbacka et al. 1992, 1994) revealed different patterns
in the different migrational categories andGypsy groups,
pointing to a history of independent recombinations and
marker mutations, and the distance where pexcess was
10.5 in all populations varied from 0.07 to 2.12 cM. In
all cases, the comparison between migrational categories
and Gypsy groups pinpointed the location of the disease-
causing mutation through the identiﬁcation of a shared
interval of complete LD ( ).p p 1excess
Normal Haplotypes
Mean D′ levels were 10.5 for marker pairs separated
by as many as ∼150 kb in all Gypsy groups (ﬁg. 6) except
in the Turgovzi for the HMSNL region ( ).′D p 0.45
Within this range, we did not observe a trend toward
decreasing D′ values with increasing distances. For the
entire length of both regions, mean D′ values were in
excess of 0.5 in three Vlax groups and 0.47 in the Tur-
govzi. The signiﬁcance, presented as P values, showed a
more variable pattern, especially for the HMSNL region
on 8q (ﬁg. 6). The patterns observed were distinctly dif-
ferent in the four Gypsy groups, reﬂecting an independent
history of random recombinations. They showed notably
greater similarity in the small D18S70-to-68530gt2 in-
terval in the CCFDN region, spanning a total of ∼70 kb.
Discussion
In this study, the detailed characterization of several dis-
ease loci was used to address hitherto unanswered ques-
tions about Gypsy population history. This is also, to
our knowledge, the ﬁrst systematic investigation of mu-
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Figure 4 Networks showing the genealogical relationships of
disease haplotypes. The size of the symbols is proportional to the
frequency of each haplotype. A, CMS haplotypes in the CHRNE re-
gion. B, HMSNL haplotypes in the NDRG1 region. C, HMSNL hap-
lotypes in Gypsy groups from the Vlax migrational category. D,
CCFDN haplotypes in the CTDP1 region. E, LGMD2C haplotypes
in the SGCG region. For CMS and HMSNL, only haplotype groups
comprising more than ﬁve unique haplotypes are shown.
tation carrier rates in a sample representative of the tra-
ditional social structure of this population.
Mutation screening revealed high carrier rates, with
an average of one in eight subjects heterozygous for
one of the mutations tested. Within individual Gypsy
groups, carrier rates 15% for speciﬁc mutations were
observed in 14 cases. These frequencies, which suggest
strong founder effects, fall within the range of estimates
for ﬁve of the most common mutations in the Finnish
and Ashkenazi Jewish populations (Pastinen et al. 2001;
Risch et al. 2003). The data indicate that recessiveMen-
delian disorders represent a considerable health burden
in the Gypsy population and, given the observed allelic
homogeneity, that carrier-testing programs in Gypsy
communities are likely to be highly beneﬁcial.
Sharing of the ﬁve mutations and related disease hap-
lotypes further supported the genetic relatedness of geo-
graphically and socially separated Gypsy groups. More-
over, we have demonstrated the identity of the CMS
1267delG mutation in Gypsy and in Indian/Pakistani
subjects, thus providing the strongest evidence to date
for the Indian origins of the Gypsies. At the same time,
the observed highly signiﬁcant differences in the distri-
bution of the ancestral mutations and of their associated
chromosomal haplotypes indicate that the population
ﬁssions that led to the formation of migrational cate-
gories and individual Gypsy groups have played the role
of profound secondary and tertiary bottleneck events,
generating internal differentiation and multiple genetic
subisolates. The time frame within which the observed
population structure originated and evolved is unclear.
Although the founding of the proto-Gypsy population
is likely to coincide with the exodus from India, pro-
posed dates range from 900 to 1,500 years before pres-
ent, and there have been suggestions of multiple migra-
tions (Turner 1926; Sampson 1927; Hancock 1987,
1999, 2000; Fraser 1992). There are also no records of
historical events that could explain and date the splits
into divergent migration routes and numerous endog-
amous groups. These could have been nonrandom and
based on preexisting internal structure.
To address these unresolved yet important issues of
population history, we used haplotype coalescence times
at independent disease loci. We reasoned that the two
most common and widespread mutations (1267delG
and R148X) are likely to be derived from the ancestral
population, an assumption supported by the identity of
the CMS 1267delG mutation in Gypsy and Indian/Pak-
istani chromosomes. Their haplotype coalescence times,
estimated for the entire set of Gypsy disease chromo-
somes, would thus correspond to the founding of the
proto-Gypsy population. The results for both loci, ob-
tained by two different approaches, support a single
recent founding event ∼800 years ago (range 650–
1,075 years) when the Reeve and Rannala (2002) ap-
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Figure 5 LD estimated by pexcess (Hastbacka et al. 1992, 1994)
for markers surrounding the founder disease mutations. Markers are
shown as equidistant from one another. Intermarker distances are
shown in ﬁgures 2 and 6. The arrows indicate the approximate location
of the disease mutation. A, LD in the CMS gene region in the three
migrational categories. B, LD in the HMSNL region in the three mi-
grational categories. C, LD in the HMSNL region in Gypsy groups
from the Vlax migrational category. D, LD in the CCFDN region for
geographically separated Rudari groups.
proach is used and ∼900 years ago when the method
of Stephens et al. (1998) is used. Although such dates
should be regarded as an upper limit and are based on
a number of assumptions (such as generation time and
growth rate), the mean of 800–900 years coincides
closely with the time of the exodus proposed by Han-
cock (2000), who links it historically to the early
Islamic invasions of India in the 11th century A.D.
Further comparisons of the CMS, HMSNL, and
LGMD2C haplotype coalescence times were per-
formed, to date the separation into migrational cate-
gories. The estimated period, ∼500–600 years ago, co-
incides with a previous dating of the founding Y
chromosome haplogroup in the Vlax Roma, ∼500
years ago (Kalaydjieva et al. 2001a). Similar and some-
what more recent estimates of 425–600 years were
obtained for individual Gypsy groups. The overlap be-
tween the time of the founding of the overall Vlax
migrational category and of its constituent groups is
plausible, since historical records suggest that the en-
slavement of Gypsies and their forced separation into
groups based on ownership and trade took place very
soon after their arrival in Romania (Hancock 1987).
Our previous analyses have producedmore recent dates,
closer to the periods of migration of these groups out
of Romania and into Bulgaria (Kalaydjieva et al. 2001a;
Chaix et al. 2004). As more information on Mendelian
disorders in both Gypsies and populations in the Indian
subcontinent becomes available, it will be important to
perform further studies to corroborate the present ﬁnd-
ings. Although more-accurate dating may be achieved
with larger samples and numbers of loci, the current
results clearly point to very recent splits and, hence, to
rapidly occurring genetic divergence.
Our earlier observations on the limited diversity of
the ancestral Indian Y chromosome and mtDNA line-
ages have led us to suggest that the European Gypsy
population was founded by a small group of related
individuals (Gresham et al. 2001). In a subsequent study
using coalescence-based methods (Kuhner et al. 1998;
Wilson and Balding 1998; Beerli and Felsenstein 2001),
we estimated the effective size of the male founding
population in individual Vlax Roma groups at ∼100
individuals per group (Chaix et al. 2004). The genetic
data are supported by the limited available information
on historical demography: according to the Ottoman
tax registry, in 1522–1523, there were a total of 5,700
Gypsies in Bulgaria (Marushiakova and Popov 1997).
The numerous extant groups of the Balkan category are
derived from this small population. The number of mu-
tation carriers among the founders would have been
very small, and random drift would have played a major
role in the genetic divergence of Gypsy groups. A sur-
prising ﬁnding of the present study is the independent
evolution of disease haplotypes and the lack of sharing,
Figure 6 Pairwise LD between markers in the HMSNL and CCFDN disease gene regions in four Gypsy groups. A, Rudari. B, Kalderash.
C, Lom. D, Turgovzi. Marker loci are listed across the bottom and down the left side. A scale indicating physical distances (in kb) between
markers is shown at the bottom. D′ values are shown in the upper left-hand triangle, and P values are shown in the lower right-hand triangle.
The shading patterns used to illustrate the scale of D′ and P values are shown above and at the right-hand side of the top panel. P values !.05
have been corrected for multiple comparisons through use of the Holm-Sidak approach (Lautenberger et al. 2000).
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pointing to a limited gene ﬂow. The present-day rules
of endogamy proscribe intermarriage between most
Gypsy groups; however, there is no historical infor-
mation on marriage patterns, and it is unclear when
these strict rules were established (Liegeois 1994). Our
data suggest that the history of endogamy is as old as
Gypsy groups, and the exchange of migrants has been
very limited throughout.
Tentative evidence of substructure in the European
Gypsy population has been provided by numerous early
studies, using classical protein markers such as blood
groups (reviewed and reanalyzed by Kalaydjieva et al.
[2001b]), that examined genetic afﬁnities between Gyp-
sies residing in different countries but failed to place the
ﬁndings in the context of the social organization of the
Gypsies and the cultural divergence of Gypsy groups.
Further support has come from recent studies of Y chro-
mosome and mtDNA diversity (Gresham et al. 2001;
Kalaydjieva et al. 2001a). Internal differentiation of a
founder population is not unique to the Gypsies; it has
been well investigated and exploited in genetic research
in Finland and Sardinia (Peltonen et al. 2000; Pastinen
et al. 2001; Angius et al. 2002). On a condensed time
scale, the population history of the Gypsies replicates
that of the Jews, with its exodus, diaspora, and sub-
sequent fragmentation into small, geographically dis-
persed and isolated communities. The ages of disease
mutations in the Gypsies can thus be likened to the
scenario described by Risch et al. (2003) for the Jewish
population. The widely distributed CMS and HMSNL
mutations were already present at the time of the found-
ing of the proto-Gypsy population, 32–40 generations
before present. LGMD2C and galactokinase deﬁciency
(Hunter et al. 2002) are more restricted and represent
the founding and expansion of the Gypsy migrational
categories 20 generations ago, whereas CCFDN falls
into the most recent “age group,” coinciding with the
founding of individual subisolates. However, unlike
the Ashkenazi Jewish population, the amalgamation of
which has already been going on for several generations,
social organization and marriage customs have main-
tained the genetic structure in the Gypsies to the present
day.
Our data on single-gene disorders point to the Gyp-
sies as a population offering unique opportunities for
the mapping of genes involved in complex disorders.
The strong primary founder effect raises expectations
of a relatively homogeneous genetic basis of complex
disorders, similar to all founder populations. The ob-
served haplotype divergence in migrational categories
and Gypsy groups illustrates the limitations of the con-
cept of universal haplotype blocks and the complexity
that can be revealed through a detailed, “magnifying
glass” examination of population history. It also pro-
vides a powerful tool for the ﬁne mapping of disease
genes. The best opportunities are presented by older
genetic variants with a wide distribution, inwhich initial
analyses aimed at the crude mapping of susceptibility
genes can be performed in traditional extended families
originating from a single Gypsy group, with no speciﬁc
advantage of any Gypsy group revealed by our current
data on background LD. Fine mapping would be greatly
facilitated by wider sampling, based on recognition of
the divergent history of multiple Gypsy groups, where
the disease locus can be placed within the small genomic
region in which all subisolates share the highest LD
values. The full potential of this interesting founder pop-
ulation can be met only by informed study designs that
acknowledge traditional social organization and its ge-
netic impact.
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